The physical‐mental health interface in the preconception period: analysis of 131 182 women planning pregnancy in the UK
BJOG: An International Journal of Obstetrics & Gynaecology · 2023
DOI: 10.1111/1471-0528.17447 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, 2023. Verfasst von Conor Tosh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mathematics and Statistics, University of Strathclyde, Glasgow, UK. Hauptthemen laut MEDLINE: Mental Health, Mental Disorders. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health Research, Public Health England, Royal College of Obstetricians and Gynaecologists.
Abstract (Originalsprache)
Objective
The physical and mental health of women prior to conception can have a significant impact on pregnancy and child outcomes. Given the rising burden of non‐communicable diseases, the aim was to explore the relation between mental health, physical health and health behaviour in women planning a pregnancy.
Methods
Cross‐sectional analysis of responses from 131 182 women to a preconception health digital education tool, providing data on physical and mental health and health behaviour. Logistic regression was used to explore associations between mental health and physical health variables.
Results
Physical health conditions were reported by 13.1% and mental health conditions by 17.8%. There was evidence for an association between self‐reported physical and mental health conditions (odds ratio [OR] 2.22, 95% CI 2.14–2.3). Those with a mental health condition were less likely to engage with healthy behaviour at preconception such as folate supplementation (OR 0.89, 95% CI 0.86–0.92) and consumption of the recommended amount of fruit and vegetables (OR 0.77, 95% CI 0.74–0.79). They were more likely to be physically inactive (OR 1.14, 95% CI 1.11–1.18), smoke tobacco (OR 1.72, 95% CI 1.66–1.78) and use illicit substances (OR 2.4, 95% CI 2.25–2.55).
Conclusions
Greater recognition of mental and physical comorbidities is needed and closer integration of physical and mental healthcare in the preconception period, which could support people to optimise their health during this time and improve long‐term outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Mathematics and Statistics, University of Strathclyde, Glasgow, UK.
- Department of Women and Children's Health, King's College London, London, UK.
- Institute for Women's Health, University College London, London, UK.
- Section of Women's Mental Health, King's College London, London, UK.
- South London and Maudsley NHS Foundation Trust, London, UK.
ORCID-Profile: Sara L White, Raquel Catalao, Claire A Wilson
Förderung
- National Institute for Health Research
- Public Health England
- Royal College of Obstetricians and Gynaecologists
- Tommy's Baby Charity
Zitieren
APA
Tosh, C., Kavanagh, K., Flynn, A. C., Stephenson, J., White, S. L., Catalao, R., & Wilson, C. A. (2023). The physical‐mental health interface in the preconception period: analysis of 131 182 women planning pregnancy in the UK. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.17447
Vancouver
Tosh C, Kavanagh K, Flynn AC, Stephenson J, White SL, Catalao R, et al. The physical‐mental health interface in the preconception period: analysis of 131 182 women planning pregnancy in the UK. BJOG: An International Journal of Obstetrics & Gynaecology. 2023. doi:10.1111/1471-0528.17447
BibTeX
@article{Tosh2023,
author = {Tosh, Conor and Kavanagh, Kimberley and Flynn, Angela C and Stephenson, Judith and White, Sara L and Catalao, Raquel and Wilson, Claire A},
title = {The physical‐mental health interface in the preconception period: analysis of 131 182 women planning pregnancy in the UK},
journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
year = {2023},
doi = {10.1111/1471-0528.17447}
}
EUVIMED